TNF and psoriasis: There has been a recent increase in popularity of perioperatively administering disease modifying antirheumatic drugs (DMARDs) such as TNF-inhibitors (TNFi) and TNF blocking agents for several weeks prior to operations to decrease inflammation associated with psoriasis, PsA, or other related conditions [16].